Moll JM, Hofland J, Teubel WJ, de Ridder CMA, et al. Abiraterone switches castration-resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling. Prostate 2022 Jan 17. doi: 10.1002/pros.24297.
PMID: 35037287